Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Kidney Transplantation

Free Subscription Articles published in Kidney Int Retrieve available abstracts of 74 articles: HTML format

Single Articles

December 2025
1. GOMPERS A, Harding JL
   Improving transplant access and outcomes for women-the importance of the patient perspective.
   Kidney Int. 2025;108:991-993.
   PubMed     Abstract available
   
   
   
2. SHEN Q, Zhu T, Yan S, Wang Y, et al
   Macrophages mediate acute kidney allograft rejection via a toll-like receptor 4-dependent mechanism.
   Kidney Int. 2025;108:1105-1122.
   PubMed     Abstract available
   
   
   November 2025
3. COZZI E
   Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA >/= 99.9.
   Kidney Int. 2025;108:748-751.
   PubMed     Abstract available
   
   
   
4. ROBERTSON H, Perkins GB
   Adopting a wider view: factoring blood, biopsy, and urine into kidney transplant outcomes.
   Kidney Int. 2025;108:745-748.
   PubMed     Abstract available
   
   
   
5. ARNOUX G, Serre J, Verissimo T, Tihy M, et al
   Integrated spatial and functional metabolic profiling identified the thick ascending limb as a mitochondrial vulnerability hub in acute kidney injury.
   Kidney Int. 2025;108:866-882.
   PubMed     Abstract available
   
   
   October 2025
6. RICO-FONTALVO J, Ciudin A, Correa-Rotter R, Diaz-Crespo FJ, et al
   S.E.N., SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification.
   Kidney Int. 2025;108:572-583.
   PubMed     Abstract available
   
   
   
7. EDER M, Kainz A, Omic H, Aigner C, et al
   A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complications.
   Kidney Int. 2025;108:669-685.
   PubMed     Abstract available
   
   
   September 2025
8. LANGE J, Queissert F, Pavenstadt H, Al-Itaibi R, et al
   An unexpected focus of infection after kidney transplantation.
   Kidney Int. 2025;108:504.
   PubMed    
   
   
   
9. BOHMIG GA, Budde K
   Intravenous immunoglobulin for chronic active antibody-mediated rejection: a signal of hope in an evolving field.
   Kidney Int. 2025;108:351-354.
   PubMed     Abstract available
   
   
   August 2025
10. LADHANI M, Jaure A, Davidson B, Barday Z, et al
    A multinational qualitative study examined the perspectives and experiences of women with a kidney transplant on access to healthcare.
    Kidney Int. 2025 Aug 25:S0085-2538(25)00658-1. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
11. REESE PP, Mohan S, Schaubel DE, Forbes R, et al
    Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection.
    Kidney Int. 2025 Aug 22:S0085-2538(25)00657-X. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
12. KUMAR T, Tiwari V, Gupta A, Rao S, et al
    Cutaneous histoplasmosis in a patient with a kidney transplant.
    Kidney Int. 2025;108:333.
    PubMed    
    
    
    July 2025
13. MURAKAMI N, Blosser CD, Webber AB, Gupta G, et al
    Management recommendations for kidney transplantation in patients with plasma cell dyscrasia.
    Kidney Int. 2025 Jul 28:S0085-2538(25)00576-9. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
14. TINEL C, Varin A, Anglicheau D, Callemeyn J, et al
    Multi-omic factor analyses uncovered cross-compartment complexity of biological processes in kidney transplantation.
    Kidney Int. 2025 Jul 7:S0085-2538(25)00512-5. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
15. ZHANG H, Sabiu G, Jung S, Podesta MA, et al
    Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity.
    Kidney Int. 2025;108:48-56.
    PubMed     Abstract available
    
    
    June 2025
16. CUCCHIARI D, Mancebo-Sierra E, Caro JL, Meneghini M, et al
    A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated Panel Reactive Antibody >/= 99.9.
    Kidney Int. 2025 Jun 6:S0085-2538(25)00427-2. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
17. RIZZOLO K, Villegas L, Cervantes L
    The national landscape of kidney transplantation for undocumented immigrants: advancing kidney transplantation equity.
    Kidney Int. 2025;107:976-979.
    PubMed     Abstract available
    
    
    
18. VAN LOON E, Gillard P, Naesens M
    SGLT2 inhibitors fulfill their expectations in diabetic kidney transplant recipients.
    Kidney Int. 2025;107:966-969.
    PubMed    
    
    
    
19. NORDHEIM E, Hovd M, Dahle DO
    Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis.
    Kidney Int. 2025;107:1113.
    PubMed    
    
    
    
20. MON-WEI YU S, Choi JY, Kady J, De Cos M, et al
    Transplantation of human kidney organoids elicited a robust allogeneic response in a humanized mouse model.
    Kidney Int. 2025;107:1011-1016.
    PubMed     Abstract available
    
    
    
21. KINOSHITA Y, Kobayashi E, Matsui K, Inage Y, et al
    Life-supporting functional kidney replacement by integration of embryonic metanephros-bladder composite tissue transplants.
    Kidney Int. 2025;107:1051-1063.
    PubMed     Abstract available
    
    
    May 2025
22. MULLEY WR, Tharmaraj D, Polkinghorne KR, Tesch GH, et al
    A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients.
    Kidney Int. 2025 May 22:S0085-2538(25)00406-5. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
23. HABBIG S, Debiec H, Chedik M, Stippel DL, et al
    Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis.
    Kidney Int. 2025 May 16:S0085-2538(25)00393-X. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
24. SEIF N, Bloom RD
    Using donor-derived cell-free DNA in kidney transplant patients: this jury needs more evidence.
    Kidney Int. 2025;107:796-799.
    PubMed    
    
    
    
25. BUDDE K, Osmanodja B, Schrezenmeier E, Halleck F, et al
    Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients.
    Kidney Int. 2025;107:792-796.
    PubMed    
    
    
    March 2025
26. RAYNAUD M, Bakker SJL, Bentall AJ, Loupy A, et al
    Glomerular filtration rate equations in kidney transplant recipients: the need for specificity.
    Kidney Int. 2025;107:568.
    PubMed    
    
    
    February 2025
27. MENON G, Metoyer GT, Li Y, Chen Y, et al
    A national registry study evaluated the landscape of kidney transplantation among presumed unauthorized immigrants in the United States.
    Kidney Int. 2025 Feb 14:S0085-2538(25)00088-2. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
28. SELCUK ZD, Atas DB, Menetlioglu G, Dericioglu V, et al
    Kaposi sarcoma and its rare presentation in a kidney transplant recipient.
    Kidney Int. 2025;107:363.
    PubMed    
    
    
    
29. HIRSCH HH
    Can you have a cake and eat it? Comparing reducing mycophenolate versus switching to everolimus for kidney transplants with new-onset BKPyV-DNAemia.
    Kidney Int. 2025;107:230-233.
    PubMed     Abstract available
    
    
    January 2025
30. HERRMANN SM, Abudayyeh A, Gupta S, Gudsoorkar P, et al
    Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology.
    Kidney Int. 2025;107:21-32.
    PubMed     Abstract available
    
    
    December 2024
31. ZANONI F, Obayemi JE, Gandla D, Castellano G, et al
    Emerging Role of Genetics in Kidney Transplantation.
    Kidney Int. 2024 Dec 20:S0085-2538(24)00913-X. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
32. KAVANAGH D, Ardissino G, Brocklebank V, Bouwmeester RN, et al
    Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum.
    Kidney Int. 2024;106:1038-1050.
    PubMed     Abstract available
    
    
    November 2024
33. VAN DEN BERG CW, Dumas SJ, Little MH, Rabelink TJ, et al
    Challenges in maturation and integration of kidney organoids for stem cell-based renal replacement therapy.
    Kidney Int. 2024 Nov 19:S0085-2538(24)00806-8. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
34. GOUTAUDIER V, Danger R, Catar RA, Racape M, et al
    Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).
    Kidney Int. 2024;106:943-960.
    PubMed     Abstract available
    
    
    October 2024
35. CAILLARD S, Meyer N, Solis M, Bertrand D, et al
    Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients.
    Kidney Int. 2024 Oct 25:S0085-2538(24)00730-0. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
36. HATTORI M
    Anti-nephrin autoantibodies: novel predictors of post-transplant recurrence of focal segmental glomerular sclerosis.
    Kidney Int. 2024;106:570-572.
    PubMed     Abstract available
    
    
    
37. BATAL I, Watts AJB, Gibier JB, Hamroun A, et al
    Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft.
    Kidney Int. 2024;106:749-752.
    PubMed    
    
    
    
38. AHMADI A, Yu J, Loza JE, Howard BC, et al
    Deceased donor kidney function and branched chain amino acid metabolism during ex vivo normothermic perfusion.
    Kidney Int. 2024;106:712-722.
    PubMed     Abstract available
    
    
    
39. HEERSPINK HJL, Eddington D, Chaudhari J, Estacio R, et al
    A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection.
    Kidney Int. 2024;106:688-698.
    PubMed     Abstract available
    
    
    September 2024
40. AGARWAL KA, Adingwupu OM, Tighiouart H, Miao S, et al
    Estimating GFR in Kidney Transplant Recipients: Considerations for Selecting Equations.
    Kidney Int. 2024 Sep 9:S0085-2538(24)00632-X. doi: 10.1016/j.kint.2024.
    PubMed    
    
    
    
41. SCHAENMAN JM
    The adaptive and innate immune systems coordinate for successful control of CMV infection.
    Kidney Int. 2024;106:364-366.
    PubMed     Abstract available
    
    
    
42. CLEENDERS E, Coemans M, Meziyerh S, Callemeyn J, et al
    An observational cohort study examined the change point of kidney function stabilization in the initial period after transplantation.
    Kidney Int. 2024;106:508-521.
    PubMed     Abstract available
    
    
    
43. PERKINS GB, Zuiani JD, Coates PT
    The innate immune cells at the heart of kidney allograft rejection.
    Kidney Int. 2024;106:348-350.
    PubMed    
    
    
    August 2024
44. WILLICOMBE M, Roberts DJ
    TRANSFUSION-INDUCED HLA SENSITISATION IN WAITLIST PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS.
    Kidney Int. 2024 Aug 22:S0085-2538(24)00573-8. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
45. ZHANG P, Sun C, Mo S, Hu C, et al
    Salvaging donated kidneys from prolonged warm ischemia during ex vivo hypothermic oxygenated perfusion.
    Kidney Int. 2024;106:273-290.
    PubMed     Abstract available
    
    
    
46. ZHANG R, Trotter PB, McCaffrey J, Fitzroy R, et al
    Assessment of biological organ age using molecular pathology in pre-transplant kidney biopsies.
    Kidney Int. 2024;106:302-316.
    PubMed     Abstract available
    
    
    July 2024
47. JOHNSON RJ, Mandell BF, Schlessinger N, Mount DB, et al
    Controversies and practical management of patients with gout and chronic kidney disease.
    Kidney Int. 2024 Jul 19:S0085-2538(24)00473-3. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
48. CORNEC-LE GALL E, Mallett AJ
    Genomics in the kidney transplant clinic: the future standard of care?
    Kidney Int. 2024;106:18-20.
    PubMed     Abstract available
    
    
    
49. RIOS IP, Nguyen CHL, Misra SS, Ryan MS, et al
    Foscarnet-induced nephropathy in a kidney transplant recipient.
    Kidney Int. 2024;106:156.
    PubMed    
    
    
    
50. ASOWATA EO, Romoli S, Sargeant R, Tan JY, et al
    Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function.
    Kidney Int. 2024;106:85-97.
    PubMed     Abstract available
    
    
    
51. WONG G, Guha C, Mallitt KA, van Zwieten A, et al
    The randomized controlled trial (NAVKIDS2) of a patient navigator program created for children with chronic kidney disease.
    Kidney Int. 2024 Jul 1:S0085-2538(24)00450-2. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    June 2024
52. TANTISATTAMO E
    Implementation science: a tool to narrow know-do gap and widen equity in kidney diseases and transplantation.
    Kidney Int. 2024;105:1322-1323.
    PubMed    
    
    
    May 2024
53. KNECHTLE SJ, Ladowski JM, Kwun J
    A pig kidney supporting human physiology.
    Kidney Int. 2024;105:921-922.
    PubMed     Abstract available
    
    
    April 2024
54. DONADEU L, Jouve T, Bin S, Hartzell S, et al
    High-dimensional Mass Cytometry identified circulating Natural Killer T-cell subsets associated with protection from Cytomegalovirus infection in kidney transplant recipients.
    Kidney Int. 2024 Apr 27:S0085-2538(24)00310-7. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
55. CORNELL LD, Shankaranarayanan D, Rodriguez PS, Damgard SE, et al
    Sickle cell disease in the kidney transplant.
    Kidney Int. 2024;105:892.
    PubMed    
    
    
    
56. LEVIN A, Ahmed SB, Carrero JJ, Foster B, et al
    Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
    Kidney Int. 2024;105:684-701.
    PubMed     Abstract available
    
    
    
57. CALLEMEYN J, Naesens M
    Back to the future: the uncharted role of T cells in chronic and unexplained microvascular inflammation.
    Kidney Int. 2024;105:669-671.
    PubMed     Abstract available
    
    
    
58. CRISTOFERI I, Varol H, van Baardwijk M, Rahiem L, et al
    Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass.
    Kidney Int. 2024;105:812-823.
    PubMed     Abstract available
    
    
    March 2024
59. MA BM, Elefant N, Tedesco M, Bogyo K, et al
    Genetic testing in kidney transplantation helped develop a morbidity gene panel for evaluation of kidney transplant recipients.
    Kidney Int. 2024 Mar 21:S0085-2538(24)00188-1. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
60. JARMI T, Luo Y, Attieh RM, Qie Y, et al
    CAR T-cell therapy-paving the way for sensitized kidney transplant patients.
    Kidney Int. 2024 Mar 21:S0085-2538(24)00159-5. doi: 10.1016/j.kint.2024.
    PubMed    
    
    
    
61. PALMER ND, Freedman BI
    APOL1-mediated and Mendelian forms of "heretofore" idiopathic collapsing glomerulopathy: lessons from Brazil.
    Kidney Int. 2024;105:437-439.
    PubMed     Abstract available
    
    
    
62. RAINA R, Jothi S, Haffner D, Somers M, et al
    Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements.
    Kidney Int. 2024;105:450-463.
    PubMed     Abstract available
    
    
    
63. SHIRAI Y, Miura K, Ishizuka K, Ando T, et al
    A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence.
    Kidney Int. 2024;105:608-617.
    PubMed     Abstract available
    
    
    
64. GILL JS, Chadban SJ
    Pretransplant screening for coronary artery disease: data are required before practice change.
    Kidney Int. 2024;105:470-472.
    PubMed     Abstract available
    
    
    February 2024
65. VENKATARAMAN K, McTaggart SJ, Collins MG
    Choosing fluids to reduce the risks of acute electrolyte disturbances in children after a kidney transplant.
    Kidney Int. 2024;105:247-250.
    PubMed     Abstract available
    
    
    
66. HAAS M
    Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence.
    Kidney Int. 2024;105:240-242.
    PubMed     Abstract available
    
    
    
67. SHAH Y, Yang H, Mueller FB, Li C, et al
    Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
    Kidney Int. 2024;105:347-363.
    PubMed     Abstract available
    
    
    
68. LOBAN K, Fadel E, Nugus P, Przybylak-Brouillard A, et al
    Living kidney donors' health care needs, experiences, and perspectives across their entire donation trajectory: a semistructured, in-depth interview study.
    Kidney Int. 2024;105:251-258.
    PubMed    
    
    
    
69. YI Z, Xi C, Menon MC, Cravedi P, et al
    A large-scale retrospective study enabled deep-learning based pathological assessment of frozen procurement kidney biopsies to predict graft loss and guide organ utilization.
    Kidney Int. 2024;105:281-292.
    PubMed     Abstract available
    
    
    January 2024
70. LUO X, Knechtle S
    The T-cell environment: may the regulatory force be with you.
    Kidney Int. 2024;105:20-22.
    PubMed     Abstract available
    
    
    October 2023
71. HAYES WN, Laing E, Brown R, Silsby L, et al
    A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).
    Kidney Int. 2023 Oct 30:S0085-2538(23)00760-3. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    
72. BUDDE K, Rostaing L
    A first small step toward personalized immunosuppression.
    Kidney Int. 2023;104:652-654.
    PubMed     Abstract available
    
    
    
73. BAILLY E, Macedo C, Ossart J, Louis K, et al
    Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56(dim)CD16(bright) natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.
    Kidney Int. 2023;104:707-723.
    PubMed     Abstract available
    
    
    August 2023
74. EMMONS BR, Batal I, Radhakrishnan J, Husain SA, et al
    Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
    Kidney Int. 2023;104:394-397.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Kidney Transplantation is free of charge.